ON
← Back to feed
Is Health Care’s AI Race Leaving Pharmacists out of Key Decisions?
United States🏛️ PoliticsCenter7 hr. ago

Is Health Care’s AI Race Leaving Pharmacists out of Key Decisions?

The article discusses the growing role of artificial intelligence in healthcare and raises concerns about whether pharmacists are being sidelined from key decision-making processes. It highlights the need for robust governance frameworks for AI implementation, emphasizing collaboration across clinical, operational, and technological domains. Dan Eduardo Gonzalez, a pharmacist and founder of ClarityRx Advisory, argues that pharmacists possess valuable expertise in medication safety, regulatory compliance, and clinical decision-making that could inform AI governance. He stresses that healthcare systems should leverage existing clinical expertise rather than starting AI governance from scratch. The piece underscores the importance of integrating governance with real-world clinical workflows and organizational culture to ensure AI supports effective patient care.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

2 reports

Newsweek logoNewsweekIndependentCenter7 hr. ago
Is Health Care’s AI Race Leaving Pharmacists out of Key Decisions?

The article discusses the growing role of artificial intelligence in healthcare and raises concerns about whether pharmacists are being sidelined from key decision-making processes. It highlights the need for robust governance frameworks for AI implementation, emphasizing collaboration across clinical, operational, and technological domains. Dan Eduardo Gonzalez, a pharmacist and founder of ClarityRx Advisory, argues that pharmacists possess valuable expertise in medication safety, regulatory compliance, and clinical decision-making that could inform AI governance. He stresses that healthcare systems should leverage existing clinical expertise rather than starting AI governance from scratch. The piece underscores the importance of integrating governance with real-world clinical workflows and organizational culture to ensure AI supports effective patient care.

Bias read (Center): While the article touches on healthcare policy and regulation, which are politically charged topics, it does not take a clear ideological stance. Instead, it presents a balanced discussion of the challenges and opportunities associated with AI in healthcare, focusing on professional expertise and协作.

Quartz logoQuartzIndependentCenter7 hr. ago
Tempus AI is acquiring cancer-monitoring firm Personalis in a $1.5 billion stock deal

Tempus AI has agreed to acquire Personalis, a cancer-monitoring company, through a $1.5 billion all-stock deal. The acquisition grants Tempus control over Personalis' NeXT Personal cancer detection test, which aims to provide early-stage cancer diagnosis. This move positions Tempus to expand its capabilities in personalized medicine and genomic data analytics. The transaction highlights growing interest in leveraging AI for healthcare innovation, particularly in oncology.

Bias read (Center): The article presents a factual business transaction without overt ideological framing. It focuses on corporate strategy and technological advancement in healthcare, which are less politically charged. While the implications of AI in healthcare could have broader societal impacts, the article doesnot

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.

Become a Supporter

Related stories